Selection of pathways differentially expressed in PCNSL tissues compared with normal lymph node tissues
| Pathway name . | Nominal P . | FDR Q . |
|---|---|---|
| Cytokine cytokine receptor interaction | < .001 | <0.001 |
| Cell adhesion molecules | < .001 | 0.002 |
| ECM receptor interaction | < .001 | 0.014 |
| Leukocyte transendothelial migration | < .001 | 0.016 |
| Focal adhesion | < .001 | 0.017 |
| Apoptosis | .002 | 0.027 |
| Signal transduction pathway | ||
| Bad pathway | < .001 | 0.008 |
| Notch signaling pathway | < .001 | 0.010 |
| JAK-STAT signaling pathway | < .001 | 0.015 |
| NF-κB pathway | .007 | 0.026 |
| Pathway name . | Nominal P . | FDR Q . |
|---|---|---|
| Cytokine cytokine receptor interaction | < .001 | <0.001 |
| Cell adhesion molecules | < .001 | 0.002 |
| ECM receptor interaction | < .001 | 0.014 |
| Leukocyte transendothelial migration | < .001 | 0.016 |
| Focal adhesion | < .001 | 0.017 |
| Apoptosis | .002 | 0.027 |
| Signal transduction pathway | ||
| Bad pathway | < .001 | 0.008 |
| Notch signaling pathway | < .001 | 0.010 |
| JAK-STAT signaling pathway | < .001 | 0.015 |
| NF-κB pathway | .007 | 0.026 |